David Greenwald, Ph.D., is Vice President, Business Development on the Biotherapeutics group and joined the Firm in 2018. He is responsible for supporting portfolio companies with their business development efforts, as well as working with the Investment Team to help source and facilitate potential opportunities. Most recently, he was Director of Business Development at Johns Hopkins Technology Ventures. Dr. Greenwald is a founder of Relay Technology Management, Inc. and co-inventor of the Relay Innovation Engine software, and previously he was Chief Executive Officer of Relay Technology Management, and Director of Client Solutions for Decision Resources Group after its acquisition of Relay. He was an Associate Investigator at the Naval Medical Research Center in Silver Spring, MD, where he worked with the Food and Drug Administration on 510(k) applications for diagnostic devices for dengue fever. Dr. Greenwald was a Howard Hughes Medical Institute research fellow while earning a B.S. in Cellular Biology and Molecular Genetics from the University of Maryland, College Park and eventually earned his Ph.D. in Genetics from Tufts University.